Detalhe da pesquisa
1.
Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension.
Circulation
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38695173
2.
Plasma Proteomics Identifies B2M as a Regulator of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction.
Arterioscler Thromb Vasc Biol
; 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38813697
3.
IL-18 mediates sickle cell cardiomyopathy and ventricular arrhythmias.
Blood
; 137(9): 1208-1218, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33181835
4.
Genetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking ß-blockers.
Pharmacogenomics J
; 22(1): 62-68, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34642472
5.
Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.
Genet Med
; 23(12): 2335-2341, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34282303
6.
Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data.
Pharmacogenomics J
; 20(5): 724-735, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32042096
7.
Beta-Blocker Dose Stratifies Mortality Risk in a Racially Diverse Heart Failure Population.
J Cardiovasc Pharmacol
; 75(3): 250-258, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31895871
8.
Association of Genetic Variants With Warfarin-Associated Bleeding Among Patients of African Descent.
JAMA
; 320(16): 1670-1677, 2018 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30357299
9.
Circulating Procollagen Type III N-Terminal Peptide and Mortality Risk in African Americans With Heart Failure.
J Card Fail
; 22(9): 692-9, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26721774
10.
Pharmacogenomics of hypertension and heart disease.
Curr Hypertens Rep
; 17(9): 586, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26272307
11.
Estimating preferences and willingness to pay for pharmacogenetic testing in populations who are medically underserved: a discrete choice experiment.
Front Pharmacol
; 15: 1384667, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38595920
12.
Feasibility of preemptive pharmacogenetic testing and improvement of medication treatment satisfaction among medically underserved patients.
Clin Transl Sci
; 17(1): e13692, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38013396
13.
Using Omics to Identify Novel Therapeutic Targets in Heart Failure.
Circ Genom Precis Med
; 17(3): e004398, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38766848
14.
Leveraging QSP Models for MIPD: A Case Study for Warfarin/INR.
Clin Pharmacol Ther
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38655898
15.
CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention.
J Am Heart Assoc
; 13(12): e033791, 2024 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38874073
16.
Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score.
J Am Coll Cardiol
; 83(15): 1370-1381, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38599713
17.
Pharmacist-guided pharmacogenetic service lowered warfarin-related hospitalizations.
Pharmacogenomics
; 24(6): 303-314, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37166395
18.
An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers.
Clin Pharmacol Ther
; 114(2): 275-287, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37303270
19.
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y12 Inhibitor Prescribing After Percutaneous Coronary Intervention.
Clin Pharmacol Ther
; 113(3): 615-623, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36306392
20.
Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide.
J Transl Med
; 10: 56, 2012 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22440088